It's not just neighborhoods: Multiple levels of influence on cervical cancer screening across multiple healthcare settings

Authors: Pruitt SL, Xiong D, Hughes AE, Borton E, Haas JS, Kobrin S, Sugg Skinner C, Zhang S

Category: Early Detection & Risk Prediction
Conference Year: 2020

Abstract Body:
Purpose: Describe variability in cervical cancer screening across multiple cross-classified levels: healthcare provider, clinic, and neighborhood of residence. Methods: We examined multilevel variation in Pap screening among patients due for screening using electronic health record (EHR) data from 3 healthcare settings in the PROSPR network. This retrospective cohort study included average-risk women aged 21-65 who completed ≥1 clinical encounter, had 3 years of EHR data, and whose addresses were linked to census tract data. We excluded women who were: HIV+, already screening up-to-date, not screening-eligible, or with history of cervical cancer or prior cervical abnormality. The outcome was Pap screen within 3 years of cohort entry (yes/no). We fit Bayesian cross-classified 4-level logistic models nesting patients within separate, non-overlapping levels (providers, clinics, census tracts). We estimated multilevel variation using Median Odds Ratios (MOR) and 95% credible interval in empty models (i.e., no covariates) and after adjusting for patient-level covariates (age, sex, race/ethnicity, BMI, pregnancy and smoking status, number of healthcare encounters, and cohort entry year). Results: Approximately half of eligible patients were screened in each setting (1: 54.4% of n=81,668; 2: 48.4% of n=42,127; 3: 47.3% of n=43,991). The magnitude of variation in Pap among all levels was similar among settings. After adjusting for patient-level covariates, the largest variation was at the clinic level (MOR range: 1.44-1.62), followed by provider (MOR range: 1.27-1.35), and neighborhood level (MOR range: 1.17-1.21). For example, we can interpret clinic-level MOR as: if a woman switched from a low-screening to a high-screening clinic, her odds of Pap screen would be 1.44-1.62 times higher. Future results will include one additional healthcare setting and will include provider-, clinic-, and neighborhood-level covariates. Conclusions: Significant and substantial variability in Pap was observed across provider, clinic, and neighborhood levels in 3 different healthcare settings, suggesting that factors at multiple levels are driving cervical cancer screening. Future interventions must identify and modify multilevel influences to reduce disparities in Pap screening.

Keywords: multilevel, cervical cancer screening, disparity, variation